Malaria Therapeutic Efficacy Study (TES) Kenya
NCT04767191
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Uncomplicated Malaria
Interventions
DRUG:
artemether lumefantrine
DRUG:
dihydroartemisinin piperaquine
Sponsor
Jhpiego
Collaborators
[object Object]
[object Object]
[object Object]